Synergy Pharmaceutical Sciences

China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has announced a licensing agreement with fellow Chinese firm Shanghai Synergy Pharmaceutical Sciences Co., Ltd. Under the terms of the agreement, Livzon will obtain all rights to Synergy Pharma’s HHT120 in Greater China, which includes mainland China, Hong Kong, Macau, and Taiwan. In…